trending Market Intelligence /marketintelligence/en/news-insights/trending/sPoVZNI9cgQJLRU3ac9ziQ2 content esgSubNav
In This List

Abattis closes acquisition of Dutch dietary supplements maker

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Abattis closes acquisition of Dutch dietary supplements maker

Abattis Bioceuticals Corp. completed its acquisition of Pro Natura BV from Catalyst Investment Capital Corp. for about €6.7 million.

Netherlands-based Pro Natura is a privately held maker of dietary supplements.

Vancouver, British Columbia-based Abattis is a life sciences and biotechnology company focused on cannabis technologies and biotechnology services for the legal cannabis industry in Canada.